Accelerate Diagnostics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 05/24/2023   Download
SEC Document
SEC Filing

On May 23, 2023, Accelerate Diagnostics, Inc. (the “Company”) filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to increase the total number of authorized shares of the Company’s capital stock to 455,000,000 shares, of which 450,000,000 shares are designated as common stock and 5,000,000 shares are designated as preferred stock. As discussed in Item 5.07 of this Current Report on Form 8-K (this “Report”) below, the Company’s shareholders approved the Certificate of Amendment on May 19, 2023 at the Annual Meeting (as defined below). Previously, the Company’s Certificate of Incorporation authorized the Company to issue 205,000,000 shares of the Company’s capital stock, of which 200,000,000 shares were designated as common stock and 5,000,000 shares were designated as preferred stock.